163 related articles for article (PubMed ID: 24026059)
1. [Photodynamic therapy of bladder cancer. A new option].
Neuhaus J; Schastak S; Berndt M; Walther J; Dietel A; Sieger N; Stolzenburg JU
Urologe A; 2013 Sep; 52(9):1225-32. PubMed ID: 24026059
[TBL] [Abstract][Full Text] [Related]
2. Reduction of Muscle-Invasive Tumors by Photodynamic Therapy with Tetrahydroporphyrin-Tetratosylat in an Orthotopic Rat Bladder Cancer Model.
Berndt-Paetz M; Schulze P; Stenglein PC; Weimann A; Wang Q; Horn LC; Riyad YM; Griebel J; Hermann R; Glasow A; Stolzenburg JU; Neuhaus J
Mol Cancer Ther; 2019 Apr; 18(4):743-750. PubMed ID: 30824608
[TBL] [Abstract][Full Text] [Related]
3. Tetrahydroporphyrin-tetratosylat (THPTS): A near-infrared photosensitizer for targeted and efficient photodynamic therapy (PDT) of human bladder carcinoma. An in vitro study.
Berndt-Paetz M; Weimann A; Sieger N; Schastak S; Riyad YM; Griebel J; Arthanareeswaran VKA; Stolzenburg JU; Neuhaus J
Photodiagnosis Photodyn Ther; 2017 Jun; 18():244-251. PubMed ID: 28279796
[TBL] [Abstract][Full Text] [Related]
4. Initiation of apoptosis by photodynamic therapy using a novel positively charged and water-soluble near infra-red photosensitizer and white light irradiation.
Schastak S; Yafai Y; Geyer W; Kostenich G; Orenstein A; Wiedemann P
Methods Find Exp Clin Pharmacol; 2008; 30(1):17-23. PubMed ID: 18389094
[TBL] [Abstract][Full Text] [Related]
5. Characterization of radical types, penetration profile and distribution pattern of the topically applied photosensitizer THPTS in porcine skin ex vivo.
Lohan SB; Kröger M; Schleusener J; Darvin ME; Lademann J; Streit I; Meinke MC
Eur J Pharm Biopharm; 2021 May; 162():50-58. PubMed ID: 33691169
[TBL] [Abstract][Full Text] [Related]
6. Chemical modification of a tetrapyrrole-type photosensitizer: tuning application and photochemical action beyond the singlet oxygen channel.
Riyad YM; Naumov S; Schastak S; Griebel J; Kahnt A; Häupl T; Neuhaus J; Abel B; Hermann R
J Phys Chem B; 2014 Oct; 118(40):11646-58. PubMed ID: 25207950
[TBL] [Abstract][Full Text] [Related]
7. Studies of the photosensitizer disulfonated meso-tetraphenyl chlorin in an orthotopic rat bladder tumor model.
Baglo Y; Peng Q; Hagen L; Berg K; Høgset A; Drabløs F; Gederaas OA
Photodiagnosis Photodyn Ther; 2015 Mar; 12(1):58-66. PubMed ID: 25575731
[TBL] [Abstract][Full Text] [Related]
8. [Photodynamic therapy of urinary bladder cancer using a chlorin based photosensitizer].
Iagudaev DM; Martov AG; Sorokatyĭ AE; Geĭnits AV
Urologiia; 2006; (3):24-7. PubMed ID: 16889085
[TBL] [Abstract][Full Text] [Related]
9. Photodynamic therapy with PAD-S31, a new hydrophilic chlorin photosensitizer, in an orthotopic rat bladder tumor model.
Asanuma H; Arai T; Morimoto Y; Kawauchi S; Satoh H; Seguchi K; Kikuchi M; Murai M
J Urol; 2005 Nov; 174(5):2016-21. PubMed ID: 16217385
[TBL] [Abstract][Full Text] [Related]
10. Tetrahydroporphyrin-tetratosylate (THPTS)-based photodynamic inactivation of critical multidrug-resistant bacteria in vitro.
Ziganshyna S; Guttenberger A; Lippmann N; Schulz S; Bercker S; Kahnt A; Rüffer T; Voigt A; Gerlach K; Werdehausen R
Int J Antimicrob Agents; 2020 Jun; 55(6):105976. PubMed ID: 32325201
[TBL] [Abstract][Full Text] [Related]
11. The effect of photodynamic therapy on rat urinary bladder with orthotopic urothelial carcinoma.
Grönlund-Pakkanen S; Wahlfors J; Talja M; Kosma VM; Pakkanen TM; Ala-Opas M; Alhava E; Moore RB
BJU Int; 2003 Jul; 92(1):125-30. PubMed ID: 12823396
[TBL] [Abstract][Full Text] [Related]
12. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat.
Schastak S; Jean B; Handzel R; Kostenich G; Hermann R; Sack U; Orenstein A; Wang YS; Wiedemann P
J Photochem Photobiol B; 2005 Mar; 78(3):203-13. PubMed ID: 15708517
[TBL] [Abstract][Full Text] [Related]
13. [Recent developments in anticancer photochemotherapy].
Santus R
Pathol Biol (Paris); 1991 Jan; 39(1):54-8. PubMed ID: 1826348
[TBL] [Abstract][Full Text] [Related]
14. Advances in Management of Bladder Cancer-The Role of Photodynamic Therapy.
Kubrak T; Karakuła M; Czop M; Kawczyk-Krupka A; Aebisher D
Molecules; 2022 Jan; 27(3):. PubMed ID: 35163996
[TBL] [Abstract][Full Text] [Related]
15. [Photodynamic therapy and urothelial carcinoma].
Colin P; Estevez JP; Betrouni N; Nevoux P; Puech P; Leroy X; Biserte J; Villers A; Mordon S
Bull Cancer; 2011 Jul; 98(7):769-78. PubMed ID: 21708516
[TBL] [Abstract][Full Text] [Related]
16. In vivo fluence rate and fractionation effects on tumor response and photobleaching: photodynamic therapy with two photosensitizers in an orthotopic rat tumor model.
Iinuma S; Schomacker KT; Wagnieres G; Rajadhyaksha M; Bamberg M; Momma T; Hasan T
Cancer Res; 1999 Dec; 59(24):6164-70. PubMed ID: 10626808
[TBL] [Abstract][Full Text] [Related]
17. Chlorin-based photodynamic therapy enhances the effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in bladder cancer cells.
Szliszka E; Czuba ZP; Kawczyk-Krupka A; Sieron-Stoltny K; Sieron A; Krol W
Med Sci Monit; 2012 Jan; 18(1):BR47-53. PubMed ID: 22207109
[TBL] [Abstract][Full Text] [Related]
18. Photodynamic therapy with the novel photosensitizer chlorophyllin f induces apoptosis and autophagy in human bladder cancer cells.
Lihuan D; Jingcun Z; Ning J; Guozeng W; Yiwei C; Wei L; Jing Q; Yuanfang Z; Gang C
Lasers Surg Med; 2014 Apr; 46(4):319-34. PubMed ID: 24464873
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy with intravesical instillation of 5-aminolevulinic acid for patients with recurrent superficial bladder cancer: a single-center study.
Berger AP; Steiner H; Stenzl A; Akkad T; Bartsch G; Holtl L
Urology; 2003 Feb; 61(2):338-41. PubMed ID: 12597942
[TBL] [Abstract][Full Text] [Related]
20. An overview on preclinical and clinical experiences with photodynamic therapy for bladder cancer.
Yavari N; Andersson-Engels S; Segersten U; Malmstrom PU
Can J Urol; 2011 Aug; 18(4):5778-86. PubMed ID: 21854709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
